Research Topics
| Michael BlaissSummaryAffiliation: University of Tennessee Country: USA Publications
| Collaborators
|
Detail Information
Publications
Pediatric allergic rhinitis: physical and mental complicationsMichael S Blaiss
Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Allergy Asthma Proc 29:1-6. 2008..It is important for the clinician to take AR in the child seriously to prevent or control complications that can have a detrimental effect on the child...- Allergic rhinitis: Direct and indirect costsMichael S Blaiss
Department of Pediatrics and Medicine, University of Tennessee Health Science Center, Memphis, 38120, USA
Allergy Asthma Proc 31:375-80. 2010..This article reviews the latest data on cost issues in allergic rhinitis and information of cost-effectiveness of treatments for this condition... 
Allergic rhinitis and impairment issues in schoolchildren: a consensus reportMichael S Blaiss
University of Tennessee Health Science Center, Germantown, TN 38138, USA
Curr Med Res Opin 20:1937-52. 2004..CONCLUSION: Existing data indicate that further studies using objective measures of impairment in children taking antihistamine medications should be conducted to evaluate the impact of disease and treatment...- Current concepts and therapeutic strategies for allergic rhinitis in school-age childrenMichael Blaiss
Division of Clinical Immunology Allergy, University of Tennessee Health Science Center, Memphis, TN, USA
Clin Ther 26:1876-89. 2004.... - Asthma disease management: a critical analysisMichael S Blaiss
College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Ann Allergy Asthma Immunol 95:S10-6. 2005..To examine how effective a number of asthma disease management (DM) programs have been and whether they have been shown to improve patient outcomes cost-effectively... - Managing asthma during pregnancy. The whys and hows of aggressive controlMichael S Blaiss
University of Tennessee Health Science Center, College of Medicine, Memphis, USA
Postgrad Med 115:55-8, 61-4. 2004..In this article, Dr Blaiss discusses the foundations for management of asthma during pregnancy: environmental control, pharmacotherapy, and allergen immunotherapy... - Expanding choices in intranasal steroid therapy: summary of a roundtable meetingMichael S Blaiss
Department of Pediatrics and Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Allergy Asthma Proc 27:254-64. 2006..Control of AR requires a systematic approach to treatment selection and follow-up. Treatment selection should be matched with clinical profile and patient preferences... - Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroidsMichael S Blaiss
University of Tennessee Health Sciences Center, Germantown, TN 38138, USA
Curr Med Res Opin 24:821-36. 2008..Treatment of the patient with ocular allergy symptoms should take into account a variety of factors, including severity of symptoms, convenience/compliance issues, and patient preferences... - Patient and healthcare-provider perspectives on the burden of allergic rhinitisMichael S Blaiss
Departmentof Pediatrics, University of Tennessee Health Science Center, 7205 Wolf River Boulevard, Germantown, TN 38138, USA
Allergy Asthma Proc 28:S4-10. 2007..Patients and healthcare professionals report that symptoms of AR are bothersome. Effective treatment options for nasal symptoms of AR may decrease the burden of illness and improve patient productivity and quality of life... - Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitisMichael S Blaiss
Department of Pediatrics and Medicine, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA
Allergy Asthma Proc 28:145-52. 2007..This review evaluates the overall safety of INS in AR and the importance of systemic safety considerations of INS, particularly when coadministered with ICS... - Expanding the evidence base for the medical treatment of nasal polyposisMichael S Blaiss
Department of Pediatrics and Medicine, University of Tennessee Health Sciences Center College of Medicine, 38138, USA
J Allergy Clin Immunol 116:1272-4. 2005 - Part II: Inhaler technique and adherence to therapyMichael S Blaiss
University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA
Curr Med Res Opin 23:S13-20. 2007..Consequently, effective education regarding the benefits of treatment and the risks of nonadherence is critical to enhancing patient adherence, self-care skills, and, potentially, asthma control... - Selecting the optimal oral antihistamine for patients with allergic rhinitisJeffrey M Lehman
Department of Pediatrics, Division of Clinical Allergy and Immunology, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Drugs 66:2309-19. 2006..In addition to the clinical efficacy, potential for improvement in QOL with a particular treatment should also be considered... - Outcomes in pediatric asthmaMichael S Blaiss
Allergy and Asthma Care, 7205 Wolf River Boulevard, Germantown, TN 38138, USA
Curr Allergy Asthma Rep 5:431-6. 2005..This article provides information regarding the different components of outcomes in pediatric asthma and how one can use outcomes to improve asthma control for the child... - Are inhaled corticosteroids safe in pregnancy?Michael S Blaiss
University of Tennessee, Health Science Center, College of Medicine, Memphis, USA
Postgrad Med 116:57. 2004 - Management of rhinitis and asthma in pregnancyMichael S Blaiss
University of Tennessee Health Science Center, College of Medicine, South Memphis, Tennessee 38018, USA
Ann Allergy Asthma Immunol 90:16-22. 2003..To objectively critique recent available data on the proper management of allergy and asthma during pregnancy, with an emphasis on understanding the risk and benefit of medications used during pregnancy for these disorders... - Medical and economic dimensions linking allergic rhinitis and asthmaMichael S Blaiss
Departments of Pediatrics and Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Allergy Asthma Proc 23:223-7. 2002..For physicians caring for these patients, an understanding of the relationship of these conditions and the magnitude of health care costs is paramount in proper treatment... - Management of asthma during pregnancyMichael S Blaiss
Department of Pediatrics and Medicine, University of Tennessee Center for the Health Sciences, College of Medicine, Memphis, Tennessee, USA
Allergy Asthma Proc 25:375-9. 2004..Other agents such as salmeterol, leukotriene modifiers, newer inhaled corticosteroids, and omalizumab may be considered in women who showed a good response to these agents before pregnancy... - Important aspects in management of allergic rhinitis: compliance, cost, and quality of lifeMichael S Blaiss
University of Tennessee Health Science Center, College of Medicine, Memphis, Tennessee, USA
Allergy Asthma Proc 24:231-8. 2003..Physicians should consider compliance, cost, and quality of life issues in each and every patient with allergic rhinitis... - Rhinitis-asthma connection: epidemiologic and pathophysiologic basisMichael S Blaiss
University of Tennessee Center for the Health Sciences, College of Medicine, Memphis, Tennessee, USA
Allergy Asthma Proc 26:35-40. 2005..It is important for the clinician to understand the connection between these disorders so that all patients with rhinitis are evaluated for lower airways disease, and all patients with asthma be screened for upper airways conditions... - Allergic rhinoconjunctivitis: burden of diseaseMichael S Blaiss
Department of Pediatrics and Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Allergy Asthma Proc 28:393-7. 2007..Proper treatment of AR patients should not only greatly improve their quality of life, but also bring down health care costs, especially indirect ones, associated with this condition... - Cost-effectiveness of H1-antihistaminesMichael S Blaiss
University of Tennessee Center for the Health Sciences, College of Medicine, Memphis, Tennessee, USA
Clin Allergy Immunol 17:319-36. 2002..Cost-effective analyses among H1-antagonists in other allergic diseases, such as atopic dermatitis, urticaria and angioedema, and asthma, are lacking at this time... - Epidemiology and pathophysiology of immunoglobulin E-mediated asthmaMichael S Blaiss
Department of Pediatrics and Medicine, University of Tennessee, Memphis, TN, USA
Allergy Asthma Proc 26:423-7. 2005..Our increasing knowledge of the underlying role of IgE in the asthmatic patient should pave the way for better treatments for this population of sufferers... - What are the best estimates of pediatric asthma control?Radha K Gandhi
Department of Clinical Allergy and Immunology, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Curr Opin Allergy Clin Immunol 6:106-12. 2006..To evaluate asthma outcome measures in the face of the variable nature of asthma. The outcome measures are divided into objective and subjective clinical measures, humanistic measures such as quality of life, and costs of asthma control... - Antihistamines: treatment selection criteria for pediatric seasonal allergic rhinitisMichael S Blaiss
Allergy and Asthma Care, Wolf River Boulevard, Suite 200, Germantown, TN 38138, USA
Allergy Asthma Proc 26:95-102. 2005.... - Pediatric asthma disease management programs--do they work?Michael S Blaiss
Ann Allergy Asthma Immunol 90:282-3. 2003 - What can we do NOW?Michael S Blaiss
Curr Opin Allergy Clin Immunol 4:111-2. 2004 - Diphenhydramine vs desloratadine comparisons must consider risk-benefit ratioMichael S Blaiss
Ann Allergy Asthma Immunol 97:121-2. 2006 - Allergic fungal sinusitis in childrenJenny M Campbell
Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Arkansas, USA
Ann Allergy Asthma Immunol 96:286-90. 2006..Typically, AFS occurs in atopic children with refractory sinus disease, requiring a high index of suspicion for evaluation and aggressive treatment... - Inhaled steroids and asthmaMichael S Blaiss
Pediatrics 110:1030-1; author reply 1030-1. 2002 - The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomesWilliam E Berger
American College of Allergy, Asthma, and Immunology, Mission Viejo, California, USA
Ann Allergy Asthma Immunol 93:538-45. 2004..37; 95% CI, 0.05-2.69). CONCLUSIONS: Our findings suggest that refinements to the HEDIS measure method for identifying patients with persistent asthma may be needed...